Alvogen Acquires 50.5% Of Korea’s Mid-Ranking KunWha Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
Alvogen’s takeover of KunWha might be a sign of more acquisitions of local companies struggling to survive harsh conditions in Korea.